Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001482981-25-000144

President & CEO sold 25,000 shares at $22.75 ($568,750)

  • President & CEO acquired 25,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cloonan Michael President & CEO 2025-08-20 Option exercise 10b5-1 +25,000 $6.11 $152,750 572,343 D: show line 1 in the form
Cloonan Michael President & CEO 2025-08-20 Sale 10b5-1 −25,000 $22.75 $568,750 547,343 D: show line 2 in the form
Open-market sales · 25,000 sh · avg $22.75 · $568,750

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cloonan Michael President & CEO 2025-08-20 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −25,000 228,142 D: show line 3 in the form
Loading xslF345X05/edgardoc.xml…